CVE Tools

CVE-2025-36226

Multiple vulnerabilities in IBM Aspera Faspex

No known exploitation. EPSS puts it in the 12th percentile. Fixed in 5.0.15.

Published Updated Sources: CVE.org, NVD

What to do

Find your product and version, then upgrade to the build on the right.

  • IBM Aspera Faspex 5Affected: ≥ 5.0.0, ≤ 5.0.14.3Upgrade to: after 5.0.14.3Stated by: CVE record
  • Ibm Aspera FaspexAffected: ≥ 5.0.0, < 5.0.15Upgrade to: 5.0.15Stated by: NVD

Versions as the sources state them. Full version matrix after sign-in

What it is

From the CVE record

IBM Aspera Faspex 5 5.0.0 through 5.0.14.3 is vulnerable to cross-site scripting. This vulnerability allows an authenticated user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.

In plain language

No plain-language summary for this CVE yet.

Exploitation

Where each signal puts this CVE on the scale from published to confirmed exploited.

EPSS12th
CISA KEV

Not in the catalog. CISA has not confirmed exploitation.

Public exploits

No public exploit or proof of concept found in the sources we track.

EPSS

0.2% chance of exploitation activity in the next 30 days, which ranks it in the 12th percentile of scored CVEs.

Exploit Prediction Scoring System, FIRST.org. A probability, not a confirmation.

Lifecycle

5 events over 2 days, from the signal feeds we watch.

  1. Patch availablerecord updated
  2. Publishedweakness classified, att&ck mapped

Affected products

Technical detail

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

Scored 5.4 by NVD.

How it is reached

  • Attack Vector NetworkExploitable remotely over the network without any special conditions
  • Attack Complexity LowNo special conditions — the attack can be reliably reproduced
  • Privileges Required LowRequires basic user-level privileges
  • User Interaction RequiredA user must click a link, open a file, or perform some action

Scope

  • Scope ChangedThe exploit can affect other components (e.g. sandbox escape, host compromise from VM)

Impact if exploited

  • Confidentiality LowSome restricted information is disclosed, but limited in scope
  • Integrity LowData modification is possible but limited in scope or consequence
  • Availability NoneNo availability impact

Weaknesses

ATT&CK techniques

Mapped from the weaknesses above (CWE to ATT&CK), not observed in attacks.

Sources

References in the record

Watch the software you run.

My Stack ranks new CVEs for your products by real-world exploitation, so the next serious one reaches you without reading every advisory.

We'll flag the next CVE, public exploit or patch for Aspera Faspex 5, not every advisory.